Archer DX
We’re right where you need us
Invitae is a leading medical genetics company with world-class germline and somatic testing in a single, comprehensive platform. ArcherDX was acquired by Invitae in October 2020 and brings the somatic oncology offerings to the platform. ArcherDX's technologies are built on its proprietary Anchored Multiplex PCR (AMPâ„¢) chemistry that enables testing services for disease risk, therapy optimization and personalized cancer monitoring to advance precision approaches to cancer treatment.
Social Media Lab at the APHA 2014 Meeting
APHA 2014